Author(s):
Rupak K. Swain, Satya N. Tripathy, Rabinarayan Rana, Sujit K. Patro, Satyajeet Behera
Email(s):
rupak.55@gmail.com
DOI:
10.52711/0975-4385.2023.00017 
Address:
Rupak K. Swain1*, Satya N. Tripathy2, Rabinarayan Rana1, Sujit K. Patro1, Satyajeet Behera1
1Department of Pharmacology, Roland Institute of Pharmaceutical Sciences, BPUT, Berhampur, 760010, Odisha, India.
2Department of Pharmaceutical Analysis, School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Bhubaneshwar, Odisha.
3Department of Pharmacology, Roland Institute of Pharmaceutical Sciences, BPUT, Berhampur, 760010, Odisha, India.
4Department of Pharmacognosy, Roland Institute of Pharmaceutical Sciences, BPUT, Berhampur, 760010, Odisha, India.
5Department of PA & QA, Roland Institute of Pharmaceutical Sciences, BPUT, Berhampur, 760010, Odisha, India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 2,
Year - 2023
ABSTRACT:
The demand for the natural drugs obtained from plant source have been ever increasing due to its negligible side effects. Arjuna scientifically known as Terminalia arjuna belongs to family Combretaceae. Arjuna finds its place in many indigenous systems of medicines like Ayurveda. Cardiovascular diseases have been a major source of death world wide, since then the evolution of many drugs happened to be the cure for cardiovascular diseases. Arjuna bark is found to be one of the potential herb with maximum cardiotonic properties. Several literature reviews confirms its potentiality. The bark of Arjuna is traditionally used in many Ayurvedic formulations for its cardiotonic, styptic, febrifuge and diuretic activities. Arjuna bark is found to contain many bioactive compounds like Gylcosides, tannins, flavonoids possessing active pharmacological actions specially Hypolipidemic activities and Antioxidant activity. The main aim of the study is to focus on the clinical and experimental studies on cardiovascular activities of Arjuna with reference to its phytochemical compounds.
Cite this article:
Rupak K. Swain, Satya N. Tripathy, Rabinarayan Rana, Sujit K. Patro, Satyajeet Behera. A Study on Phytochemical and Pharmacological activity of Terminalia arjuna: A Review. Research Journal of Pharmacognosy and Phytochemistry. 2023; 15(2):111-7. doi: 10.52711/0975-4385.2023.00017
Cite(Electronic):
Rupak K. Swain, Satya N. Tripathy, Rabinarayan Rana, Sujit K. Patro, Satyajeet Behera. A Study on Phytochemical and Pharmacological activity of Terminalia arjuna: A Review. Research Journal of Pharmacognosy and Phytochemistry. 2023; 15(2):111-7. doi: 10.52711/0975-4385.2023.00017 Available on: https://rjpponline.org/AbstractView.aspx?PID=2023-15-2-3
REFERENCES:
1. Heinrich M. Ethnobotany and its role in drug development. Phytother Res. 2000; 14:479-88
2. Tabuti JR, Lye KA, Dhillion SS. Traditional herbal drugs of Bulamogi, Uganda: Plants, use and administration. J Ethnopharmacol. 2003; 88:19-44.
3. Ayyanar M, Sankarasivaraman K, Ignacimuthu S. Traditional herbal medicines used for the treatment of diabetes among two major tribal groups in south Tamil Nadu, India. Ethnobot Leaf. 2008; 12:276-80.
4. Chopra RN, Ghosh S. Terminalia Arjuna: Its Chemistry, Pharmacology and Therapeutic Action. Ind Med Gaz. 1929; 64(2): 70-3. PMID: 29009552.
5. Biswas M, Bhattacharya S, Ghosh AK, et al. Antitumour activity of Terminalia arjuna leaf against Ehrlich ascites carcinoma in mice. Nat Prod Res. 2012; 26(12): 1141-4.
6. Harborne JB. Indian Medicinal Plants. A Compendium of 500 Species. J Pharm Pharmacol. Warrier P K, Nambiar V P K, Ramankutty. C. 1994; Vol.1: pp. (11): 935-935.
7. Sharma SK, Sharma D, Agarwal N. Diminishing effect of arjuna tree (Terminalia arjuna) bark on the lipid and oxidative stress status of high fat high cholesterol fed rats and development of certain dietary recipes containing the tree bark for human consumption. Res Pharm. 2012; 2: 22-30.
8. Subramaniam S, Ramachandran S, Uthrapathi S, Gnamanickam VR, Dubey GP. Anti-hyperlipidemic and antioxidant potential of different fractions of Terminalia arjuna Roxb. bark against PX- 407 induced hyperlipidemia. Indian J Exp Biol. 2011; 49(4): 282-8. PMID: 21614892.
9. Gauthaman K, Mohamed Saleem TS, Ravi V. Sita Sharan Patel, Niranjali Devaraj S. Alcoholic Extract of Terminalia Arjuna Protects Rabbit Heart against Ischemic-Reperfusion Injury: Role of Antioxidant Enzymes and Heat Shock Protein. Int J Biol Life Agric Sci. 2008; 2(6): 112-22.
10. Gauthaman K, Maulik M, Kumari R, Manchanda SC, Dinda AK, Maulik SK. Effect of chronic treatment with bark of Terminalia arjuna: a study on the isolated ischemic-reperfused rat heart. J Ethnopharmacol. 2001; 75(2-3): 197-201. http://dx.doi.org/10.1016/S0378-8741(01)00183-0 PMID: 11297851
11. Parveen A, Babbar R, Agarwal S, Kotwani A, Fahim M. Mechanistic clues in the cardioprotective effect of Terminalia arjuna bark extract in isoproterenol-induced chronic heart failure in rats. Cardiovasc Toxicol. 2011; 11(1): 48-57.
12. Mandal S, Patra A, Samanta A, et al. Analysis of phytochemical profile of Terminalia arjuna bark extract with antioxidative and antimicrobial properties. Asian Pac J Trop Biomed. 2013; 3(12): 960-6. http://dx.doi.org/10.1016/S2221-1691(13)60186-0 PMID: 24093787
13. Subramaniam S, Ramachandran S, Uthrapathi S, Gnamanickam VR, Dubey GP. Anti-hyperlipidemic and antioxidant potential of different fractions of Terminalia arjuna Roxb. bark against PX- 407 induced hyperlipidemia. Indian J Exp Biol. 2011; 49(4): 282-8. PMID: 21614892
14. Sivalokanathan S, Ilayaraja M, Balasubramanian MP. Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Mol Cell Biochem. 2006; 281(1-2): 87-93.
15. Sinha M, Manna P, Sil PC. Terminalia arjuna protects mouse hearts against sodium fluoride-induced oxidative stress. J Med Food. 2008; 11(4): 733-40.
16. Verma N, Vinayak M. Effect of Terminalia arjuna on antioxidant defense system in cancer. Mol Biol Rep. 2009; 36(1): 159-64. http://dx.doi.org/10.1007/s11033-008-9279-3 PMID: 18537039.
17. Dwivedi S 2007. Terminalia arjuna Wight and Arn: a useful drug for cardiovascular disorders. Journal of Ethnopharmacology. 114(2): 114-129.
18. Ram A, Lauria P, Gupta R, Kumar P, Sharma VN. Hypocholesterolaemic effects of Terminalia arjuna tree bark. JEthnopharmacol. 1997; 55:165-69.
19. Bachaya HA, Iqbal Z, Khan MN, Jabbar A, Gilani AH, Din IU. In vitro and in vivo anthelmintic activity of Terminalia arjuna bark. Int J Agric Biol. 2009; 11:273-8.
20. Phanikumar G, Navya K, Ramya EM, Venkataramana M, Anand T, Anilakumar KR. DNA damage protecting and free radical scavenging properties of Terminalia arjuna bark in PC-12 cells and plasmid DNA. Free Radic Antioxid. 2013; 3:35-9.
21. Dwivedi S. Terminalia arjuna Wight and Arn.- a useful drug for cardiovascular disorders. J Ethnopharmacol 2007; 114:114-29.
22. Dwivedi S, Udupa N. Terminaliaarjuna: Pharmacognosy, phytochemistry, pharmacology and clinical use a review. Fitoterapia. 1989; 60:413-20
23. Fan, C., Dong, Y., Xie, Y., Su, Y., Zhang, X., Leavesley, D., et al. (2015). Shikonin reduces TGF-b1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts. Int. J. Mol. Med. 36, 985–991. doi: 10.3892/ijmm.2015.2299.
24. Cock, I. (2015). The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae). Inflammopharmacology. 23, 203–229. doi: 10.1007/s10787-015-0246-z
25. Zhang, X.-R., Kaunda, J. S., Zhu, H.-T., Wang, D., Yang, C.-R., and Zhang, Y.-J. (2019). The genus Terminalia (Combretaceae): An ethnopharmacological, phytochemical and pharmacological review. Natural Prod. Bioprospect. 9, 357–392. doi: 10.1007/s13659-019-00222-3.
26. Row LR, Murty PS, Subbarao GSR, et al; Chemical examination of Terminalia species. Part XIII. Isolation and structure determination of arjunetin from Terminalia arjuna. Ind J Chem., 1970b; 8:772-775.
27. Kapoor D, Vijayvergiya R, Dhawan V. Terminalia arjuna in coronary artery disease: ethnopharmacology, pre-clinical, clinical and safety evaluation. J Ethnopharmacol. 2014; 155:1029e1045.
28. Chopra RN, Chopra IC, Handa KL, Kapur LD. Terminalia arjuna WandA (Combretaceae). In: Chopra RN, Chopra IC, Handa KL, Kapur LD, eds. Chopra's Indigenous Drugs of India. 1st ed. Calcutta, India: UNDhur and Sons; 1958:421e424.
29. Nadkarni AK. Indian Materia Medica. 1st ed. Mumbai, India: Popular Prakashan; 1976.
30. Ali A, Kaur G, Hamid H. Terminoside A, a new triterpineglycoside from the bark of Terminalia arjuna inhibits nitricoxide production in murine macrophages. Journal of Asian Natural Product Research. 2003; 5:137- 142.
31. Ansari JA, Singh A, Neeraj, Pandey R, Sushma. Effects of Dietary Arjuna (Terminalia Arjuna) Bark Powder Supplementation on SerumBiochemical of Broilers. Indo American Journal of Pharmaceutical Sci. 2016; 3(1):1-4.
32. Shah CS, Bhavsar GC; Pharmacognosy of the bark of Terminalia tomentosa Wand A and comparison with Terminalia arjuna Wand A bark. Ind J Pharmacol. 1956; 18:81-84.
33. Kaur K, Arora S, Kumar S, Nagpal A; Modulatory effect of phenolic fractions of Terminalia arjuna on the mutagenicity in Ames assay. J Environ Pathol Toxicol Oncol. 2002; 21:45-56.
34. Dhiman AK. Ayurvedic Drug Plants, 7th Edition. New Delhi. Daya Publishing House; 2006, pp 41-43
35. A. L. Miller, “Botanical Influences on Cardiovascular Disease, ” Alternative Medicine Review. 1998; 3(6): 422–431.
36. R. N. Chopra, I. C. Chopra, K. L. Anand et al., Chopra’s Indigenous Drugs of India, vol. 2, Academic publishers, 1982.
37. Abraham, A., Mathew, L., and Samuel, S. Pharmacognostic studies of the fruits of Terminalia bellirica (Gaertn.) Roxb. J. Pharmacognosy Phytochem. 2014; 3: 45–52.
38. Chaudhari MG, Mahajan TR. Comprehensive study on pharmacognistic, phsico and phytochemical evaluation of Terminalia arjuna Roxb. Stem bark. Journal of Pharmacognosy and Phytochem. 2015; 4(3):186-193.
39. Chitlange SS, Kulkarni SP, Patil D, Patwardhan B, Nanda RK. High- Performance Liquid Chromatographic Fingerprint for Quality Control of Terminalia Arjuna Containing Ayurvedic Churna Formulation. Journal of Aoac Int. 2009; 4(92)..
40. Gaikwad D, Jadhav N. A review on biogenic properties of stem bark of Terminalia Arjuna: An update. Asian Journal of Pharmaceutical and Clinical Research, 2018; 11(8): 35-38
41. Singh DV, Verma RK, Gupta MM, Kumar S. Quantitative determination of oleane derivatives in Terminalia arjuna by high performance thin layer chromatography. Phytochem Anal. 2002; 13:207e210.
42. Singh DV, Verma RK, Singh SC, Gupta MM. RP-LC determinationof oleane derivatives in Terminalia arjuna. J Pharm Biomed Anal. 2002; 28:447e452.
43. Chitlange SS, Kulkarni PS, Patil D, Patwardhan B, Nanda RK. High-performance liquid chromatographic fingerprint for quality control of Terminalia arjuna containing Ayurvedic churna formulation. J AOAC Int. 2009; 92:1016e1020.
44. Kokkiripati PK, Kamsala RV, Bashyam L, et al. Stem-bark of Terminalia arjuna attenuates human monocytic (THP-1) and aortic endothelial cell activation. J Ethnopharmacol. 2013; 146:456e464
45. Jiby Elias, Rajesh M.G., Anish N.P., Manu M.S., Iwin C. Varkey. Terminalia chebula Retz. Stem Bark Extract: A Potent Natural Antioxidant. Asian J. Research Chem. 2011; 4(3): 445-449.
46. Row LR, Murty PS, SubbaRao GSR, Sastry CSP, Rao KVJ. Chemical examination of Terminalia arjuna: Part-XII: isolation and structure determination of arjunic acid, a new trihydroxytriterpene carboxylic acid from Terminalia arjuna bark. Indian J Chem. 1970; 8:716e721
47. Honda T, Murae T, Tsuyuki T, Takahashi T, Sawai M. Arjungenin, arjunglucoside I and arjunglucoside II, a new triterpene and new triterpene-glucosides from Terminalia arjuna. Bull Chem Soc Jpn. 1976; 49:3213e3218.
48. Singh DV, Verma RK, Gupta MM, Kumar S. Quantitative determination of oleane derivatives in Terminalia arjuna by high performance thin layer chromatography. Phytochem Anal. 2002; 13:207e210.
49. Singh DV, Verma RK, Singh SC, Gupta MM. RP-LC determinationof oleane derivatives in Terminalia arjuna. J Pharm Biomed Anal. 2002; 28:447e452.
50. Singh DV, Verma RK, Gupta MM, Kumar S. Quantitative determination of oleane derivatives in Terminalia arjuna by high performance thin layer chromatography. Phytochem Anal. 2002; 13:207e21
51. Singh DV, Verma RK, Singh SC, Gupta MM. RP-LC determinationof oleane derivatives in Terminalia arjuna. J Pharm Biomed Anal. 2002; 28:447e452
52. Singh DV, Verma RK, Gupta MM, Kumar S. Quantitative determination of oleane derivatives in Terminalia arjuna by high performance thin layer chromatography. Phytochem Anal. 2002; 13:207e21
53. Singh DV, Verma RK, Singh SC, Gupta MM. RP-LC determinationof oleane derivatives in Terminalia arjuna. J Pharm Biomed Anal. 2002; 28:447e452.
54. Honda T, Murae T, Tsuyuki T, Takahashi T, Sawai M. Arjungenin, arjunglucoside I and arjunglucoside II, a new triterpene and new triterpene-glucosides from Terminalia arjuna. Bull Chem Soc Jpn. 1976; 49:3213e3218.
55. Honda T, Murae T, Tsuyuki T, Takahashi T. The structure of arjungen: a new sapogenin from Terminalia arjuna. Chem Pharm Bull. 1976; 24:178e180.
56. Row LR, Murty PS, SubbaRao GSR, Sastry CSP, Rao KVJ. Chemical examination of Terminalia arjuna: Part-XII: isolation and structure determination of arjunic acid, a new trihydroxytriterpene carboxylic acid from Terminalia arjuna bark. Indian J Chem. 1970; 8:716e721
57. Row LR, Murty PS, Subba Rao GSR, Sastry CSP, Rao KVJ. Chemical examination of Terminalia arjuna: Part-XII: Isolation and structure determination of arjunetin from Terminalia arjuna bark. Indian J Chem. 1970; 8:772e775.
58. Sharma PN, Shoeb A, Kapil RS, Popli SP. Arjunolone: a new flavones from stem bark of Terminalia arjuna. Indian J Chem. 1982; 21B:263e264
59. Alam MS, Kaur G, Ali A, Hamid H, Ali M, Athar M. Two new bioactive oleanane triterpene glycoside from Terminalia arjuna. Nat Prod Res. 2008; 22: 1279e1288.
60. Takahashi SH, Tanaka H, Hano Y, Ito KT, Nomura T, Shigenobu K. Hypotensive effects in rats of hydrophilic extract from Terminalia arjuna containing tannin related compounds. Phytother Res. 1997; 11:424-7.
61. Lin TC, Chien SC, Chen HF, Hsu FL. Tannins and related compounds from Combretaceae plants. Chin Pharm J. 2000; 52:1-26.
62. Kuo PL, Hsu YL, Lin TC, Lin LT, Chang JK, Lin CC. Casuarinin from the bark of Terminalia arjuna induces apoptosis and cell cycle arrest in human breast adenocarcinoma MCF-7cells. Planta Med. 2005; 71:237-43.
63. Kuo PL, Hsu YL, Lin TC, Lin LT, Chang JK, Lin CC. Casuarinin from the bark of Terminalia arjuna induces apoptosis and cell cycle arrest in human breast adenocarcinoma MCF-7cells. Planta Med. 2005; 71:237-43.
64. Kuo PL, Hsu YL, Lin TC, Lin LT, Chang JK, Lin CC. Casuarinin from the bark of Terminalia arjuna induces apoptosis and cell cycle arrest in human breast adenocarcinoma MCF-7cells. Planta Med. 2005; 71:237e243.
65. Sharma PN, Shoeb A, Kapil RS, Popli SP. Arjunolone: a new flavones from stem bark of Terminalia arjuna. Indian J Chem. 1982; 21B:263e264.
66. Pettit GR, Hoard MS, Doubek DL, et al. Antineoplastic agents 338. The cancer cell growth inhibitory. Constituents of Terminalia arjuna (Combretaceae). J Ethnopharmacol. 1996; 53:57e63.
67. Anonymous. Terminalia arjuna. Altern Med Rev. 1999; 4:436e437.
68. Anonymous. Terminalia arjuna. Altern Med Rev. 1999; 4:436e437.
69. Anonymous. Terminalia arjuna. Altern Med Rev. 1999; 4:436e437.
70. Saha A, Pawar VM, Jayaraman S. Characterization of polyphenols in Terminalia arjuna bark extract. Indian J Pharm Sci. 2012; 74:339e347.
71. Dwivedi S, Udupa N. Terminalia arjuna: pharmacognosy, phytochemistry, pharmacology and clinical use: a review. Fitoterpia. 1989; 60:413e420.
72. Honda T, Murae T, Tsuyuki T, Takahashi T, Sawai M. Arjungenin, arjunglucoside I and arjunglucoside II, a new triterpene and new triterpene-glucosides from Terminalia arjuna. Bull Chem Soc Jpn. 1976; 49:3213e3218.
73. Honda T, Murae T, Tsuyuki T, Takahashi T. The structure of arjungen: a new sapogenin from Terminalia arjuna. Chem Pharm Bull. 1976; 24:178e180.
74. Anjaneyulu ASR, Prasad AVR. Chemical examination of the roots of Terminalia arjuna characterization of two new triterpenoidglycoside. Indian J Chem. 1982; 21:530e533.
75. Anjaneyulu ASR, Prasad AVR. Chemical examination of roots of Terminalia arjuna-the structure of arjunoside III andarjunoside IV, two new triterpenoid glycosides. Phytochemistry. 1982; 21:2057e2060.
76. Ali A, Kaur G, Hamid H, et al. Terminoside A, a new triterpineglycoside from the bark of Terminalia arjuna inhibits nitricoxide production in murine macrophages. J Asian Nat Prod Res. 2003; 5:137e142.
77. Ali A, Kaur G, Hayat K, Ali M, Ather M. A novel naphthanolglycoside from Terminalia arjuna with antioxidant and nitricoxide inhibitory activities. Pharmazie. 2003; 58:932e934.
78. Ali A, Kaur G, Hamid H, et al. Terminoside A, a new triterpineglycoside from the bark of Terminalia arjuna inhibits nitricoxide production in murine macrophages. J Asian Nat Prod Res. 2003; 5:137e142.
79. Alam MS, Kaur G, Ali A, Hamid H, Ali M, Athar M. Two new bioactive oleanane triterpene glycoside from Terminalia arjuna. Nat Prod Res. 2008; 22: 1279e1288.
80. Wang W, Ali Z, Shen Y, Li X, Khan IA. Ursane triterpenoids from the bark of Terminalia arjuna. Fitoterapia. 2010; 81:480e484 .
81. Wang W, Ali Z, Li XC, Shen Y, Khan IA. 18, 19-Secooleananetype triterpeneglycosylesters from the bark of Terminalia arjuna. Planta Med. 2010; 76: 903e908.
82. Lin TC, Chien SC, Chen HF, Hsu FL. Tannins and related compounds from Combretaceae plants. Chin Pharm J. 2001; 52:1e26.
83. Kolodziej H, Kiderlen AF. Anti-leishmanial activity and immunemodulatory effects of tannins and related compounds on Leishmania parasitised RAW264.7 cells. Phytochemistry. 2005; 66:2056e2071
84. Chaudhari M, Mengi S. Evaluation of phytoconstituents of Terminalia arjuna for wound healing activity in rats. Phytother Res. 2006; 20:799e805.
85. Gangadevi V, Muthumary J. Taxol production byPestalotiopsisterminaliae, an endophytic fungus ofTerminalia arjuna(arjun tree). Biotechnology and applied Biochem. 2009; 52(1):9-15
86. Ghadge P, Giramkar S, Sangwan M, Kulkarni O, Wele A, Kuvalekar A et al. In Vitro Free Radical Scavenging Potential of Common Traditional Ayurvedic Extract: KashayaAnd Ksheerpaka; International Journal of Pharmacy and Pharmaceutical Sci. 2013; 5(3):676-679.
87. Dubey SK, Batra A. Study of anti oxidant and anti-inflammatory activity from ethanol fraction of Thuja occidentalis Linn. Research J. Science and Tech. 2009; 1(1):39-42.
88. (Bajpai M, Pande A, Tewari SK, Prakash D. Phenolic contents and antioxidant activity of some food and medicinal plants. Int J Food Sci Nutr. 2005; 56: 287e291.
89. Fuhrman B, Aviram M. Antiatherogenecity of nutritional compounds. I Drugs. 2001; 4:82e92.
90. Carluccio MA, Sicuella L, Ancora MA, et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol. 2003; 23: 622e629.
91. Dwivedi S. Terminalia arjuna Wight and Arn.- A useful drug for cardiovascular. Journal of Ethnopharmacol. 2007; 114:114-129.
92. A. Singh, V. Bajpai, S. Kumar, B. Kumar, M. Srivastava, K.B. Rameshkumar, Ind. Crop Prod. 87, 236–246 (2016)
93. Dwivedi S, Udupa N. Terminalia arjuna: pharmacognosy, phytochemistry, pharmacology and clinical use: a review. Fitoterpia. 1989; 60:413e420.
94. Shreya Mandal et al./Asian Pac J Trop Biomed. Analysis of phytochemical profile of Terminalia arjuna bark extract with antioxidative and antimicrobial properties. 2013; 3(12): 960-966, doi:10.1016/S2221-1691(13)60186-0.
95. Honda T, Murae T, Tsuyuki T, Takahashi T. The structure of arjungen: a new sapogenin from Terminalia arjuna. Chemical Pharmaceutical Bull. 1976; 24:178- 180)
96. Ghoshal LM, Terminalia arjuna. Ph.D. thesis, Calcutta University, Calcutta, India; 1909.
97. Gupta LP, Sen SP, Udupa KN. Pharmacological studies on Terminalia arjuna. Journal of Research in Indian Medicine, Yoga and Homeopathy. 1976; 11:16–24.
98. Bhatia J, Bhattacharya SK, Mahajan P, Dwivedi S. Effect of Terminalia arjuna on coronary flow—an experimental study (Abstract). Indian Journal of Pharmacology. 1998; 30:118- 120.
99. Preeti Tiwari. Phenolics and Flavonoids and Antioxidant Potential of Balarishta Prepared by Traditional and Modern Methods. Asian J. Pharm. Ana. 4(1): Jan.-Mar. 2014; Page 05-10.
100. Singh DV, Verma RK, Gupta MM, Kumar S. Quantitative determination of oleane derivatives in Terminalia arjuna by high performance thin layer chromatography. Phytochemical Anal. 2002; 13:207-210.
101. Sawale PD, Pothuraju R, Hussain SA, Kumar A, Kapilab S, Patil GR. Hypolipidaemic and anti-oxidative potential of encapsulated herb (Terminalia arjuna) added vanilla chocolate milk in high cholesterol fed rats. Journal of Food Science and Agri. 2016; 96:1380-1385.
102. Preeti Tiwari. Phenolics and Flavonoids and Antioxidant Potential of Balarishta Prepared by Traditional and Modern Methods. Asian J. Pharm. Ana. 4(1): Jan.-Mar. 2014; Page 05-10.
103. P. Muthukumaran, P. Shanmuganathan, C. Malathi. In Vitro Antioxidant Evaluation of Mimosa pudica. Asian J. Pharm. Res. 2011; 1(2): 44-46.
104. Bincy Raj, Soosamma John, Abdul Rasheed A. R. Pharmacognostic and Preliminary Phytochemical Screening of Ampelocissus indica including Antioxidant Activity. Res. J. Pharmacognosy and Phytochem. 2020; 12(2): 80-82.
105. Seth S, Dua P, Maulik KS. Potential benefits of Terminalia arjuna in cardiovascular disease. Journal of Preventive Cardiol. 2013; 3(1):428-432.)
106. Jadhav Sameer S., Salunkhe Vijay R. Magdum Chandrakant S.. Daily Consumption of Antioxidants: Prevention of Disease is better than Cure. Asian J. Pharm. Res. 2013; 3(1): 33-39.
107. Valli G, Jeyalakshmi M. Preliminary Phytochemical and Antioxidant Study of Odina woodier Leaf Extract. Asian J. Pharm. Res. 2012; 2(4): 153-155.
108. Singh DV, Verma RK, Singh SC, Gupta MM. RP-LC determinationofoleane derivatives in Terminalia arjuna. Journal of Pharmaceutical and Biomedical Anal. 2002; 28:447-452.
109. Thiagarajan H, Sivasami P, Chidambaram B, Bhakthavatsalam MM, Rengarajulu P. Arjunolic acid: A novel phytomedicine with multifunctional therapeutic applications. Indian Journal of Experimental Biology. 2010; 48:238-247.
110. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal Plants used in Ayurveda. CCRAS, New Delhi, 2005.
111. UK Karmakar, KS Rahman, NN Biswas, MA Islam, MI Ahmed, MC Shill, P Paul, M Kamruzzaman. Antidiarrheal, Analgesic and Antioxidant Activities of Trapa bispinosa Roxb. Fruits. Research J. Pharm. and Tech. 2011; 4(2): 294-297.
112. M.S. Alam, G. Kaur, A. Ali, H. Hamid, M. Ali, M. Athar, Nat. Prod. Res. 22, 1279–1288 (2008).
113. Mohini Shelke, Avesh Tamboli, Pankaj Sonawane, Priyanka Sadaphal, S.D. Mankar. A Review on Pharmacognosy and Pharmacological Activity of Carica papaya Leaf. Research Journal of Pharmacognosy and Phytochemistry. 2021; 13(4): 200-4.